Showing posts with label Apotex. Show all posts
Showing posts with label Apotex. Show all posts

Friday, 31 July 2026

 Stephan's Friday Picks

  • This is your home on GLP-1s (Architectural Digest)
  • Coca-Cola reached for nostalgia. Did it get Marlboro instead (NYT)
  • Apotex emerges as only manufacturer of generic Ozempic for now (Globe and Mail)
  • The unsexy habit that turned a college dropout into a $300 million founder (Forbes)
  • From the archives (2018): The other side of Barry Sherman (Maclean's)